# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
B of A Securities analyst Kevin Fischbeck maintains Humana (NYSE:HUM) with a Neutral and raises the price target from $342 t...
Leading health insurer and health care services company Humana Inc. (NYSE:HUM) announced today that Jim Rechtin will assume the...